Recent Updates
Recently added Catalysts
PEPG Negative Sentiment Score: 20/100

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Key Takeaway: A securities class action lawsuit has been initiated against PepGen Inc. for alleged misrepresentations concerning the safety and effectiveness of their lead product candidate, PGN-EDO51. This lawsuit, which encompasses securities purchased between March 7, 2024, and March 3, 2025, has prompted Bernstein Liebhard LLP to notify investors of their rights. Investors may join the class action or become lead plaintiffs by filing necessary papers by August 8, 2025. The law firm emphasizes that representation is provided on a contingency fee basis, ensuring no upfront costs for shareholders.

Market Sentiment Analysis

CONCERNS & RISKS

  • A securities class action lawsuit has been filed due to misrepresentations regarding PGN-EDO51's effectiveness and safety.
  • Investors have experienced large losses, prompting the alert from Bernstein Liebhard LLP.
  • There is uncertainty and potential financial liability for PepGen Inc. due to the lawsuit.

Full Press Release Details

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, inclusive.
For more information, submit a form at PepGen Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030.
According to the lawsuit, defendants made misrepresentations concerning the effectiveness and safety of its lead product candidate, PGN-EDO51.
If you wish to serve as lead plaintiff for the Class, you must file papers by August 8, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Tags

Frequently Asked Questions

What is the PepGen Inc. lawsuit about?

The lawsuit alleges misrepresentations regarding the effectiveness and safety of PGN-EDO51.

Who can be a lead plaintiff in the case?

Anyone wishing to serve as lead plaintiff must file papers by August 8, 2025.

Are there fees for participating in the lawsuit?

All representation is on a contingency fee basis; no fees or expenses for shareholders.

How long has Bernstein Liebhard LLP been operating?

Bernstein Liebhard LLP has been operational since 1993 and has recovered over $3.5 billion.

How can investors contact Bernstein Liebhard LLP?

Investors can contact them via email at pallocco@bernlieb.com or call (212) 951-2030.

Last updated: Jun 10, 2025